Concepedia

Author

James Stec

The University of Texas MD Anderson Cancer Center

Also Known As

J Stec, J. Stec, J. Štec, J.J. Stec, James J Stec, James J. Stec, James Joseph Stec, James Stec

56

Publications

6K

Citations

26

H-Index

47

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterMillennium Engineering and Integration (United States)Albany Medical Center HospitalTakeda (Japan)ImmunoGen (United States)
JS

About

James Stec is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

384

2

Health Sciences

2

2

173

3

Public Health

2

2

85

4

Biostatistics

2

2

147

5

Engineering

1

1

11

James Stec

×

20

Publications

4.4K

Citations

18

H-Index

YearCitations

Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

Roman Rouzier, Charles M. Perou, W. Fraser Symmans,

Clinical Cancer Research

2005

1.9K

Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer

Mark Ayers, W. Fraser Symmans, James Stec,

Journal of Clinical Oncology

2004

566

Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer

Roman Rouzier, Radhika Rajan, Peter J. Wagner,

Proceedings of the National Academy of Sciences

2005

407

Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population

James Stec, Halit Silbershatz, Geoffrey H. Tofler,

Circulation

2000

337

Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.

Lajos Pusztai, Mark Ayers, James Stec,

PubMed

2003

234

Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma

W. Fraser Symmans, Mark Ayers, Edwin Clark,

Cancer

2003

175

Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy

Lynn C. Hartmann, Karen H. Lu, Gerald P. Linette,

Clinical Cancer Research

2005

142

Effect of marathon running on inflammatory and hemostatic markers

Arthur J. Siegel, James Stec, Izabella Lipinska,

The American Journal of Cardiology

2001

138

Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits

Cheng-guang Yang, Ana M. González-Angulo, James M. Reuben,

Annals of Oncology

2006

133

Global Gene Expression Changes During Neoadjuvant Chemotherapy for Human Breast Cancer

Thomas A. Buchholz, David Stivers, James Stec,

The Cancer Journal

2002

97

Page 1